DUBLIN--(BUSINESS WIRE)--The "Single-cell Analysis Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global single-cell analysis market.
This report focuses on single-cell analysis market which is experiencing strong growth. The report gives a guide to the single-cell analysis market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
The global single-cell analysis market is expected to grow from $2.58 billion in 2021 to $2.9 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The single-cell analysis market is expected to grow to $4.9 billion in 2026 at a CAGR of 14.1%.
Companies Mentioned
- Becton Dickinson and Company
- Merck KGAA
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Fluidigm Corporation
- 10X Genomics
- Bio-Rad Laboratories
- Novogene Corporation
- Agilent Technologies Inc.
- Sartorius AG
- Luminex Corporation
- Fluxion Biosciences
- Oxford Nanopore Technologies
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The single-cell analysis market consists of sales of single-cell analysis products and services by entities (organizations, sole traders, and partnerships) that are engaged in conducting research and experimental development in single-cell analysis. Single-cell analysis is the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the level of a single cell. It helps in standardizing and automating the workflows with information useful in the treatment of various diseases such as cancer.
The main types of single-cell analysis are consumables and instruments. Consumables are used in exosome analysis, research and genetic exploration, and isolation of RNA and DNA. The workflow of single-cell analysis is single-cell isolation & library preparation, downstream analysis, data analysis using techniques such as flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, other techniques. There are various applications of single-cell analysis such as cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, and other applications. The end-users are academic and research laboratories, biotechnology and pharmaceutical companies, hospital and diagnostic laboratories.
North America was the largest region in the single-cell analysis market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The single-cell analysis market research report is one of a series of new reports that provides single-cell analysis market statistics, including single-cell analysis industry global market size, regional shares, competitors with a single-cell analysis market share, detailed single-cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis industry. This single-cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The growing focus on personalized medicine across the globe is contributing to the growth of the single-cell analysis market. Personalized medicine is a medical practice that uses a genetic profile of a particular individual to make decisions for the treatment of a disease and also for the prevention and diagnosis of the disease for that specific individual. The single-cell analysis could help in the treatment of various diseases by giving deep insights into the needs of individual patients, the nature of the disease, and the personalized treatment for it.
Thus, more patients are opting for personalized medicines for themselves. For example, according to the survey conducted in July 2021, by Dosis, a dosing platform provider, of 1,000 people, 85% of patients think that personalized medicine will improve care for them and 80% of patients think that personalized medicine should be available for all. Hence, the increasing focus on personalized medicine is supporting the growth of the market.
Companies in the single-cell analysis market are focusing on technological advancements to deliver intact and viable single cells. With the help of technological advancements, companies in the market are maintaining sample integrity through shipping, storage, and processing, increasing the recovery rates of delicate cells, and also eliminating the need for specialized instruments.
For more information about this report visit https://www.researchandmarkets.com/r/75zdic
